Inside Innovation

LPC West and Invesco Real Estate have purchased a nine-story building in South Lake Union, known as Cascadian, for $164.5 million with the intention of

The Howard Hughes Medical Institute (HHMI) has recognized 33 scientists across the U.S. for outstanding scientific research, rewarding them with a total of $300 million.

In September, several life sciences companies attended the East West Life Science Summit hosted by Life Science Washington, discussing the many benefits to starting their

Adaptive Biotechnologies, a Seattle-based biotech company founded to search for cures to cancer, is now expanding its mission to develop solutions to fight COVID-19 by

Alpine Immune Sciences announced it is raising approximately $91 million to continue developing two drugs through a private placement. Frazier Life Sciences Public Fund is

A-Alpha Bio, a Seattle-based startup raised $20 million in a Series A funding round to continue studying which proteins bind with each other. Moving forward

Impel NeuroPharma announced Trudhesa, a drug used to treat migraines, has officially received approval from the U.S. Food and Drug Administration. John Hoekman originally co-founded

During an era of mass investment in the biotech industry and vast innovation, many technology company executives are making the switch to the life science

Out of the 11 biotech companies entering the public market in the last year, eight have been from Washington state. Just this summer, three companies,

Washington-based biotech company, Bristol Myers Squibb, has received a December 23rd decision date from the FDA. If passed, Orencia, a drug originally approved for patients

Real estate investment into the life sciences reached more than $9 billion in the first half of 2021, signaling a potential record-breaking year for industry

Washington is the third cleanest state in the U.S. according to a recent study by Filter King, an air filter delivery company The results of